The US Food and Drug Administration (FDA) announced that it has approved the combination vaccine Menhibrix against two potentially life-threatening bacteria that cause meningitis in children after reviewing how effective the vaccine was in hundreds of infants and toddlers. Menhibrix, manufactured by GlaxoSmithKline Biologicals, based in Rixensart, Belgium, is indicated for infants and toddlers